AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Takatsuki, K Kawahara, S Takehara, K Kishimoto, Y Kirino, Y
Citation: K. Takatsuki et al., Effects of the noncompetitive NMDA receptor antagonist MK-801 on classicaleyeblink conditioning in mice, NEUROPHARM, 41(5), 2001, pp. 618-628

Authors: Yamada, Y Tomonaga, M Fukuda, H Hanada, S Utsunomiya, A Tara, M Sano, M Ikeda, S Takatsuki, K Kozuru, M Araki, K Kawano, F Niimi, M Tobinai, K Hotta, T Shimoyama, M
Citation: Y. Yamada et al., A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303, BR J HAEM, 113(2), 2001, pp. 375-382

Authors: Yagita, M Huang, CL Umehara, H Matsuo, Y Tabata, R Miyake, M Konaka, Y Takatsuki, K
Citation: M. Yagita et al., A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation, LEUKEMIA, 14(5), 2000, pp. 922-930

Authors: Asou, N Suzushima, H Nishimura, S Okubo, T Yamasaki, H Osato, M Hoshino, K Takatsuki, K Mitsuya, H
Citation: N. Asou et al., Long-term remission in an elderly patient with mantle cell leukemia treated with low-dose cyclophosphamide, AM J HEMAT, 63(1), 2000, pp. 35-37

Authors: Sonoki, T Matsuzaki, H Nagasaki, A Hata, H Yoshida, M Matsuoka, M Kuribayashi, N Kimura, T Harada, N Takatsuki, K Mitsuya, H Mori, M
Citation: T. Sonoki et al., Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis byNOS inhibitor, LEUKEMIA, 13(5), 1999, pp. 713-718

Authors: Etoh, K Yamaguchi, K Tokudome, S Watanabe, T Okayama, A Stuver, S Mueller, N Takatsuki, K Matsuoka, M
Citation: K. Etoh et al., Rapid quantification of HTLV-I provirus load: Detection of monoclonal proliferation of HTLV-I-infected cells among blood donors, INT J CANC, 81(6), 1999, pp. 859-864

Authors: Fujii, S Fujimoto, K Shimizu, K Ezaki, T Kawano, F Takatsuki, K Kawakita, M Matsuno, K
Citation: S. Fujii et al., Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34(+) hematopoietic progenitor cells: Induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients, CANCER RES, 59(9), 1999, pp. 2150-2158

Authors: Shimomura, T Fujii, S Ezaki, I Osato, M Fujimoto, K Takatsuki, K Yamamoto, K Kawakita, M
Citation: T. Shimomura et al., Characterization of T-cell receptor beta chain mRNA expression in IFN-alpha-responsive chronic myelogenous leukaemia patients, BR J HAEM, 105(1), 1999, pp. 173-180

Authors: Osato, M Asou, N Abdalla, E Hoshino, K Yamasaki, H Okubo, T Suzushima, H Takatsuki, K Kanno, T Shigesada, K Ito, Y
Citation: M. Osato et al., Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2 alpha B gene associated with myeloblastic leukemias, BLOOD, 93(6), 1999, pp. 1817-1824

Authors: Kuribayashi, N Hata, H Matsuzaki, H Yoshida, M Sonoki, T Nagasaki, A Kimura, T Harada, N Takatsuki, K
Citation: N. Kuribayashi et al., Establishment of a monoclonal antibody to human myeloma cell: relation to chemotherapy and extramedullar infiltration, MED ONCOL, 15(4), 1998, pp. 248-254
Risultati: 1-10 |